Detection of Rifampin-and Isoniazid-Resistant Genes in Mycobacterium Tuberculosis Clinical Isolates

Part of book or chapter of book English OPEN
Zin, Noraziah Mohamad; Hussain, Nor Farha; Isa, Rahizan; Ghani, Mohamed Kamel A; Sidik, Nik Marzuki;
(2012)
  • Publisher: InTech
  • References (5)

    [1] WHO, 2008. Global Tuberculosis Control 2008, Surveillance,Planning, Financing.WHO Regional Ocfie For the Western Pacicfi

    Johnson R., Streicher E.M., Louw G.E., Warren R.M. 2008. Drug Resistance inM. tuberculosis. Curr. Issues Mol. Biol. 8: 97-112

    Sajduda, A., Brzostek A., Popławska M., Augustynowicz-Kopec E., Zwolska Z., Niemann S., Dziadek J., and Hillemann D. 2004. Molecular Characterization of Rifampin- and IsoniazidResistant Mycobacterium tuberculosis strains Isolated in Poland. Journal of Clinical Microbiology. 42(6): 2425-2431

    Suhaila, H., Rahizan, I., Nik Marzuki S. and Noraziah M. Zin, 2008. The Usefulness of PCR Amplicfiation for Direct Detection of M. tuberculosis DNA from Clinical Samples. Biotechnology 7(1): 100-105

    Leven, M. and Goossens,H. 1997.Relevance of nucleic acid amplicfiation techniques for diagnostis of respiratory transinfections in the clinical laboratory. Clinical Microbiology Review.10:242 Wilson, M.L, Stone, B.L and Hildred, M.V. 1995. Comparison of recovery rates of mycobacteria from BACTEC 12B vials, Middlebrook 7H11 selective biplates and Lowenstein-Jensen slants in a public health mycobacteriology laboratory. Journal of Clinical Microbiology 33: 2516-2518

  • Metrics
    No metrics available
Share - Bookmark

  • Download from
    InTech via InTech (Part of book or chapter of book, 2012)
  • Cite this publication